JHS Svendgaard Laboratories Ltd Financials
Company Logo

JHS Svendgaard Laboratories Ltd Financial Statement

JHS Svendgaard Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2025
Revenue24.45
Operating Expense21.79
Net Profit1.06
Net Profit Margin4.34
Earning Per Share0.12
EBIDTA3.10
Effective Tax RateTBA

JHS Svendgaard Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual92.00
Operating Expenses Annual96.00
Operating Profit Annual-3.99
Interest Annual0.57
Depreciation7.32
Net Profit Annual-19.74
Tax Annual7.24

JHS Svendgaard Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning8.87
Cash Flow from Operations-4.96
Cash Flow from Investing-20.25
Cash Flow from Financing23.07
Cash Flow at the End6.72

JHS Svendgaard Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)-1.34
PBIT Margin (%)-9.98
PBT Margin (%)7.53
Net PROFIT Margin (%)-21.46
Return On Networth / Equity (%)TBA
Return On Networth /Employed (%)TBA
Return On Assets (%)-10.94
Total Debt / Equity (X)0.03
Asset Turnover Ratio (%)0.51

JHS Svendgaard Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual90.33
Total Current Assets Annual53.80
Non Current Assets Annual147.77
Total Shareholders Funds Annual173.13
Total Assets Annual201.57

JHS Svendgaard Laboratories Ltd Earning Calls

EPS (INR)

Expected

0.12

Reported

0.12

Surprise

0.00%

Mar 2025

EPS beaten by 0.00%

Dec 2024

EPS beaten by 0.00%

Sep 2024

EPS beaten by 0.00%

FAQS on JHS Svendgaard Laboratories Ltd Financials

As of Sep 16, 2025, JHS Svendgaard Laboratories Ltd has a market capitalization of 95.62 Cr. Value Research classifies it as a Micro-Cap company.

Yes, JHS Svendgaard Laboratories Ltd is with a debt-to-equity ratio of 0.04.

In FY 2024 , JHS Svendgaard Laboratories Ltd recorded a total revenue of approximately 92 Cr marking a significant milestone in the company's financial performance.

JHS Svendgaard Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.0% and 0.0% annually, respectively..

JHS Svendgaard Laboratories Ltd's current PE ratio is -4.84.

JHS Svendgaard Laboratories Ltd's ROCE averaged -2.9% from the FY ending March 2023 to 2025, with a median of -2.1%. It peaked at -1.7% in March 2024, reflecting strong capital efficiency over the period..

JHS Svendgaard Laboratories Ltd's latest EBIT is Rs. -11.93 Cr, surpassing the average EBIT of Rs. -12.43 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions